Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
Author Department
Medicine
Document Type
Article, Peer-reviewed
Publication Date
2-1-2007
Abstract
BACKGROUND: We evaluated the efficacy and safety of oral posaconazole for human immunodeficiency virus (HIV)-infected subjects with oropharyngeal candidiasis (OPC) and/or esophageal candidiasis (EC) who were clinically refractory to treatment with oral fl
Publication ISSN
0884-8734
Recommended Citation
Clin Infect Dis. 2007 Feb 15;44(4):607-14. Epub 2007 Jan 17.
COinS